Blog

‘Off-the-Shelf’ Fix Stops Lethal Stem Cell Transplant Flaw – Medscape


Medscape

'Off-the-Shelf' Fix Stops Lethal Stem Cell Transplant Flaw
Medscape
PHILADELPHIA — Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTLs) generated from a bank of normal donor T cells put aggressive EBV-associated lymphoproliferative disorder (LPD) refractory to rituximab into long-lasting remission in more …
New T Cell–based Immunotherapy Shows Promise for Lethal Stem Cell HealthCanal.com


Breakthrough T-Cell Therapy Halts EBV-Associated Lymphoproliferative DisordersOncLive

all 7 news articles »

2015-04-20 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.